Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy, & Use of Decellularized Femoral Artery Allograft for Arteriovenous Access for Hemodialysis: A Multi-center Prospective Registry Study

NCT05880537 is registered in ClinicalTrials.gov with LifeNet Health as lead sponsor.

NCT NCT05880537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy, & Use of Decellularized Femoral Artery Allograft for Arteriovenous Access for Hemodialysis: A Multi-center Prospective Registry Study
Lead sponsor
LifeNet Health
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2023
Completion date
December 15, 2028
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease